COVID-19: all 7,774 studies
Page 76 of 78. Open to participants first (482), then studies with results posted, then the rest; newest registration first within each.
- Pyridostigmine in Severe SARS-CoV-2 InfectionStatus unknownNCT04343963Phase 2/3
- Using Biovitals® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19Status unknownNCT04343794Not applicable
- National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19CompletedNCT04343781
- An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical TrialCompletedNCT04343768Phase 2
- Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19Status unknownNCT04343742
- COPING With COVID-19( CWC-19)WithdrawnNCT04343690Not applicable
- Mental Health Assessment Among Community Member During the Covid-19 Pandemic in IndonesiaStatus unknownNCT04343664
- Evolution of Psychoactive Substances Consumption in Connection With COVID-19 ContainmentCompletedNCT04343339
- Hyperbaric Oxygen Therapy (HBOT) as a Treatment for COVID-19 (COVID-19) InfectionWithdrawnNCT04343183Not applicable
- Trial Evaluating Efficacy and Safety of Nivolumab (Optivo®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort.Status unknownNCT04343144Phase 2
- Coronavirus Response - Active Support for Hospitalised Covid-19 PatientsWithdrawnNCT04343001Phase 3
- COVID-19 Community Research PartnershipCompletedNCT04342884
- Healthcare Worker Exposure Response and Outcomes (HERO) Registry Study, COVID-19CompletedNCT04342806
- A Study on the Prospective Cohort Library of COVID-19 in SoutheranStatus unknownNCT04342702
- Chloroquine Diphosphate in the Prevention of SARS in Covid-19 InfectionCompletedNCT04342650Phase 2
- COVID-19 Endoscopy SurveyCompletedNCT04342637
- Hydroxychloroquine for COVID-19TerminatedNCT04342221Phase 3
- Acquiring Convalescent Specimens for COVID-19 AntibodiesCompletedNCT04342195
- Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study)TerminatedNCT04342182Phase 2/3
- Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19WithdrawnNCT04342156Phase 3
- NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory FailureStatus unknownNCT04342104
- Effects of DPP4 Inhibition on COVID-19WithdrawnNCT04341935Phase 4
- A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 PandemicStatus unknownNCT04341922Not applicable
- Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIROSuspendedNCT04341870Phase 2/3
- Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect PatientCompletedNCT04341792
- Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid (Coronavirus Disease) 19CompletedNCT04341766
- Efficiency and Satisfaction With Telephone Consultation in Neuro-urology: Experience of the COVID-19 PandemicCompletedNCT04341714
- A Clinical Trial of Gargling Agents in Reducing Intraoral Viral Load Among COVID-19 PatientsStatus unknownNCT04341688Not applicable
- Non-contact ECG Sensor System for COVID19Status unknownNCT04341506
- The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19Status unknownNCT04341480
- Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients OutcomeTerminatedNCT04341415Not applicable
- A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector)CompletedNCT04341389Phase 2
- Early Versus Late ECMO Therapy in COVID-19 Induced ARDS (ECMO-VID)WithdrawnNCT04341285Not applicable
- Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer PatientsStatus unknownNCT04341207Phase 2
- Clinical and Immunological Characterisation of COVID-19 in Children, Adolescents and AdultsStatus unknownNCT04341168
- AlloSure Guided Immuno-Optimization for COVID-19: An Early ExperienceStatus unknownNCT04341103
- Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung InjuryStatus unknownNCT04341038Phase 3
- Hydroxychloroquine for the Treatment of Mild COVID-19 DiseaseTerminatedNCT04340544Phase 2
- French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management StudyCompletedNCT04340466
- Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare ProfessionalsStatus unknownNCT04340349Early Phase 1
- Safety and Efficacy of Baricitinib for COVID-19WithdrawnNCT04340232Phase 2/3
- Oncology-patient-reported Anxiety, Mood, and QoL During the COVID-19 PandemicCompletedNCT04340219
- Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS)CompletedNCT04339998
- Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled TrialTerminatedNCT04339816Phase 3
- Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and VolunteersCompletedNCT04339790
- Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ DysfunctionCompletedNCT04339712Phase 2
- Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 PneumoniaStatus unknownNCT04339660Phase 1/2
- Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With PolypharmacyCompletedNCT04339634
- Max COVID19- StudyStatus unknownNCT04339608
- Characteristics and Outcome of Coronavirus Disease 2019 (COVID-19) in EgyptStatus unknownNCT04339322
- Ruxolitinib in Covid-19 Patients With Defined HyperinflammationCompletedNCT04338958Phase 2
- COVID-19 and Deep Venous ThrombosisCompletedNCT04338932
- HOME-CoV: Hospitalization or Outpatient ManagEment of Patients With a SARS-CoV-2 InfectionCompletedNCT04338841Not applicable
- Nitric Oxide Inhalation Therapy for COVID-19 Infections in the EDTerminatedNCT04338828Phase 2
- Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19Status unknownNCT04338802Phase 2
- Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCTCompletedNCT04338698Phase 3
- The Impact of the Covid-19 Outbreak on Emergency Room Attendances of Surgical PatientsStatus unknownNCT04338672
- Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation StudyStatus unknownNCT04338568Not applicable
- Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19Approved for marketingNCT04338360
- CAP-1002 in Severe COVID-19 DiseaseNo longer availableNCT04338347
- Tranexamic Acid (TXA) and Corona Virus 2019 (COVID19) in InpatientsWithdrawnNCT04338126Phase 2
- Point Of Care UltraSonography for Risk-stratification of COVID-19 PatientsCompletedNCT04338100
- Dynamic Evaluation of COVID-19 Diagnostic TestsCompletedNCT04337996Not applicable
- Gerontological Telemonitoring of Older Adults Living in Nursing Homes With COVID-19 DiseaseWithdrawnNCT04337788Not applicable
- Beat COVID-19 - Observational TrialStatus unknownNCT04337762
- Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare SystemCompletedNCT04337541Not applicable
- Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe/Very Severe COVID-19 IllnessNo longer availableNCT04337359
- Evaluation of Covid 19 Anxiety in Endometriosis PatientsCompletedNCT04337346
- Maternal And Neonatal Outcome of Pregnant Patients With COVID-19 in Istanbul, Turkey: A Single-Center, Retrospective, Descriptive StudyCompletedNCT04337320
- Covid-19 Pediatric ObservatoryStatus unknownNCT04336956
- Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19Status unknownNCT04336904Phase 3
- Physical Activity Level, Stress Level, Sleep Quality in Pregnant Women During Covid-19 QuarantineCompletedNCT04336787
- CAPTION AI to Minimize Risk of COVID ExposureWithdrawnNCT04336774Not applicable
- Corona-Like Illness: Did we Got it Before WHO Announcement of the Disease?Status unknownNCT04336657
- Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19Status unknownNCT04336462Not applicable
- Impact of Covid-19 in Congenital Heart DiseaseCompletedNCT04336384
- Outcomes of Patients With COVID-19 in the Intensive Care UnitCompletedNCT04336345
- Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 PatientsStatus unknownNCT04336254Phase 1/2
- Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection DiseaseTerminatedNCT04335786Phase 4
- Checkpoint Blockade in COVID-19 PandemicTerminatedNCT04335305Phase 2
- Defibrotide in COVID-19 PneumoniaCompletedNCT04335201Phase 2
- COVID-19 Registry Rhineland-Palatinate (Germany)CompletedNCT04335188
- Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home IsolationCompletedNCT04335097Not applicable
- A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 InfectionCompletedNCT04335084Phase 2
- Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19)TerminatedNCT04335071Phase 2
- Interest of the Use of Pulmonary Ultrasound in the Referral of Patients With or Suspected COVID-19 +CompletedNCT04335019
- Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19CompletedNCT04334980Phase 1
- Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of CareSuspendedNCT04334967Phase 4
- Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare PersonnelCompletedNCT04334928Phase 3
- Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 PneumoniaCompletedNCT04334850Not applicable
- A Study of Quintuple Therapy to Treat COVID-19 InfectionCompletedNCT04334512Phase 2
- Telerehabilitation in Individuals Over 65 Years of Age Having Social Isolation Due to Coronavirus (Covid-19)CompletedNCT04334434Not applicable
- Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19Status unknownNCT04334382Phase 3
- International COVID19 Clinical Evaluation Registry,CompletedNCT04334291
- Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019Status unknownNCT04334265Not applicable
- Descriptive Study Regarding Ambulant Screening During COVID-19 PandemiaCompletedNCT04334252
- Treatment of SARS Caused by COVID-19 With RuxolitinibCompletedNCT04334044Phase 1/2
- Vitamin D on Prevention and Treatment of COVID-19Status unknownNCT04334005Not applicable
- COVID-19 in Patients With HIVCompletedNCT04333953
- Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 InfectionCompletedNCT04333914Phase 2